KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $80.90 $93.35 Friday, 26th Apr 2024 BMRN stock ended at $80.91. This is 1.53% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.71% from a day low at $80.90 to a day high of $83.09.
90 days $80.90 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Apr 12, 2016 $83.03 $85.39 $82.26 $85.00 1 235 718
Apr 11, 2016 $85.58 $86.28 $82.67 $83.20 1 145 644
Apr 08, 2016 $88.77 $89.35 $84.02 $85.21 1 393 106
Apr 07, 2016 $89.00 $91.91 $86.66 $87.79 1 810 635
Apr 06, 2016 $83.01 $89.43 $82.95 $89.34 1 820 683
Apr 05, 2016 $83.99 $84.70 $82.48 $83.02 808 606
Apr 04, 2016 $85.67 $87.17 $84.34 $84.47 1 040 677
Apr 01, 2016 $81.46 $86.72 $81.03 $84.66 1 592 730
Mar 31, 2016 $79.09 $84.12 $78.35 $82.48 2 162 392
Mar 30, 2016 $79.37 $81.50 $77.10 $78.29 779 470
Mar 29, 2016 $79.01 $79.93 $76.42 $78.76 1 455 000
Mar 28, 2016 $81.35 $81.45 $78.87 $79.00 713 300
Mar 24, 2016 $80.82 $83.01 $78.42 $80.87 1 545 400
Mar 23, 2016 $83.18 $85.32 $80.34 $80.61 2 186 800
Mar 22, 2016 $77.46 $83.66 $77.46 $83.43 2 615 100
Mar 21, 2016 $76.13 $79.81 $75.90 $78.19 2 746 400
Mar 18, 2016 $77.81 $81.47 $77.08 $80.94 2 456 900
Mar 17, 2016 $80.40 $80.40 $74.67 $77.32 2 961 100
Mar 16, 2016 $82.81 $84.00 $78.61 $80.34 1 462 800
Mar 15, 2016 $85.44 $85.55 $82.40 $83.43 1 147 000
Mar 14, 2016 $87.52 $88.76 $85.47 $85.98 1 452 100
Mar 11, 2016 $84.60 $88.54 $83.59 $88.27 1 301 500
Mar 10, 2016 $86.54 $86.54 $81.32 $83.60 1 288 300
Mar 09, 2016 $85.86 $86.21 $82.51 $85.22 1 489 500
Mar 08, 2016 $89.36 $90.46 $85.29 $85.54 1 330 800
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT